X4 Pharmaceuticals Stock (NASDAQ: XFOR) stock price, news, charts, stock research, profile.
You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.
Other companies in X4 Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS), PepGen (NASDAQ:PEPG) and Abpro Hldgs (NASDAQ:ABP).
X4 Pharmaceuticals has a consensus price target of $3.94.
The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $0.6304 last updated December 23, 2024 at 4:24 AM EST.
There are no upcoming dividends for X4 Pharmaceuticals.
X4 Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for X4 Pharmaceuticals.
X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.